Neurootology

This preliminary report is an account of 21 consecutive patients who had tinnitus of the severe disabling type and were examined with quantitative electroencephalography (QEEG).

This study was conducted in an attempt to determine the efficacy of neurofeedback (NFB) in the treatment of patients suffering from vertigo or tinnitus. Results indicated that after NFB, power for delta and theta bands was reduced; however, an increase of power was noted for the alpha bands.

This study reports 21 patients who suffered from vertigo and underwent a complete otorhinolaryngological evaluation and otoneurological tests to establish a peripheral labyrinthine disorder.

Tinnitus as a symptom remains a serious multidisciplinary problem. Vertigo or dizziness is not noticed frequently in tinnitus patients, so vestibular function is not often studied.

This paper describes, from a technologic and mathematical point of view, a systematic method for daily patient’s equilibrium evaluation during the clinical work.

Cochlear implantation has been performed for 16 years by investigators at Semmelweis University. During this period, different types of cochlear implants have been used and, in 30% of cases, hearing was observed to be restored in the nonimplanted ear.

The tinnitus can be functionally measured and localized through sensorymotor and neurosensorial tests. According to our Data Bank, 60% of the patients requiring a consultation show cardiocirculatory background. This figure has moved us to study cerebral vascular processes on those patients consulting only on tinnitus symptom.

In this report, we summarize our clinical experience with intratympanic dexamethasone treatment (IDT) for control of tinnitus.

During the last half century, medical developments have expedited an increase of expectation of life, all over the world. This extension of life has made that some pathologies that in former years were considered of low prevalence, nowadays they have become top priority for public health.

In a randomized, double-blind clinical study, we evaluated the efficacy and tolerability of the fixed combination of cinnarizine, 20 mg, and dimenhydrinate, 40 mg (Arlevert [ARL]) in comparison to betahistine dimesylate (12 mg) in 82 patients suffering from Ménière’s disease for at least 3 months and showing the characteristic triad of symptoms (paroxysmal vertigo attacks, […]